Potentiation of NMDA receptor-mediated excitotoxicity linked with intrinsic apoptotic pathway in YAC transgenic mouse model of Huntington's disease

Molecular and Cellular Neuroscience

Volumn 25, Issue 3, 2004, Pages 469-479

  Zeron, Melinda M ^a   Fernandes, Herman B ^a   Krebs, Claudia ^a   Shehadeh, Jacqueline ^a   Wellington, Cheryl L ^a,b   Leavitt, Blair R ^a,b   Baimbridge, Kenneth G ^a,b   Hayden, Michael R ^a   Raymond, Lynn A ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BONGKREKIC ACID; CASPASE 3; CASPASE 8; CASPASE 9; CYCLOSPORIN A; HUNTINGTIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR STIMULATING AGENT; POLYGLUTAMINE; UBIDECARENONE;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; BRAIN CELL; CALCIUM TRANSPORT; CELL DEATH; CONTROLLED STUDY; DRUG EFFECT; ENERGY METABOLISM; ENZYME ACTIVATION; GENOTYPE; HUNTINGTON CHOREA; MEMBRANE DEPOLARIZATION; MITOCHONDRIAL MEMBRANE; MOUSE; NONHUMAN; PERMEABILITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE; WILD TYPE;

ANIMALS; APOPTOSIS; CELLS, CULTURED; CHROMOSOMES, ARTIFICIAL, YEAST; DISEASE MODELS, ANIMAL; HUNTINGTON DISEASE; MICE; MICE, TRANSGENIC; NEOSTRIATUM; RECEPTORS, N-METHYL-D-ASPARTATE;

MUS MUSCULUS;

EID: 1642295805     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcn.2003.11.014     Document Type: Article

References (60)

1. Abdel-Hamid K.M., Baimbridge K.G. The effects of artificial calcium buffers on calcium responses and glutamate-mediated excitotoxicity in cultured hippocampal neurons. Neuroscience. 81:1997;673-687.
2. Alano C.C., Beutner G., Dirksen R.T., Gross R.A., Sheu S.S. Mitochondrial permeability transition and calcium dynamics in striatal neurons upon intense NMDA receptor activation. J. Neurochem. 80:2002;531-538.
3. Albin R.L., Young A.B., Penney J.B., Handelin B., Balfour R., Anderson K.D., Markel D.S., Tourtellotte W.W., Reiner A. Abnormalities of striatal projection neurons and N-methyl-D-aspartate receptors in presymptomatic Huntington's disease. (see comments) N. Engl. J. Med. 322:1990;1293-1298.
4. Ankarcrona M., Dypbukt J.M., Bonfoco E., Zhivotovsky B., Orrenius S., Lipton S.A., Nicotera P. Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron. 15:1995;961-973.
5. Beal M.F. Coenzyme Q10 administration and its potential for treatment of neurodegenerative diseases. BioFactors. 9:1999;261-266.
6. Beal M.F., Kowall N.W., Ellison D.W., Mazurek M.F., Swartz K.J., Martin J.B. Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid. Nature. 321:1986;168-171.
7. Bonfoco E., Krainc D., Ankarcrona M., Nicotera P., Lipton S.A. Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc. Natl. Acad. Sci. U. S. A. 92:1995;7162-7166.
8. Cepeda C., Ariano M.A., Calvert C.R., Flores-Hernandez J., Chandler S.H., Leavitt B.R., Hayden M.R., Levine M.S. NMDA receptor function in mouse models of Huntington disease. J. Neurosci. Res. 66:2001;525-539.
9. Cha J.H. Transcriptional dysregulation in Huntington's disease. Trends Neurosci. 23:2000;387-392.
10. Chen N., Luo T., Wellington C., Metzler M., McCutcheon K., Hayden M.R., Raymond L.A. Subtype-specific enhancement of NMDA receptor currents by mutant huntingtin. J. Neurochem. 72:1999;1890-1898.
11. Christie J.M., Jane D.E., Monaghan D.T. Native N-methyl-D-aspartate receptors containing NR2A and NR2B subunits have pharmacologically distinct competitive antagonist binding sites. J. Pharmacol. Exp. Ther. 292:2000;1169-1174.
12. DiFiglia M., Sapp E., Chase K., Schwarz C., Meloni A., Young C., Martin E., Vonsattel J.P., Carraway R., Reeves S.A.et al. Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons. Neuron. 14:1995;1075-1081.
13. Ferrante R.J., Kowall N.W., Beal M.F., Richardson E.P. Jr., Bird E.D., Martin J.B. Selective sparing of a class of striatal neurons in Huntington's disease. Science. 230:1985;561-563.
14. Ferrante R.J., Gutekunst C.A., Persichetti F., McNeil S.M., Kowall N.W., Gusella J.F., MacDonald M.E., Beal M.F., Hersch S.M. Heterogeneous topographic and cellular distribution of huntingtin expression in the normal human neostriatum. J. Neurosci. 17:1997;3052-3063.
15. Fiore C., Trezeguet V., Le Saux A., Roux P., Schwimmer C., Dianoux A.C., Noel F., Lauquin G.J., Brandolin G., Vignais P.V. The mitochondrial ADP/ATP carrier: structural, physiological and pathological aspects. Biochimie. 80:1998;137-150.
16. Ghasemzadeh M.B., Sharma S., Surmeier D.J., Eberwine J.H., Chesselet M.F. Multiplicity of glutamate receptor subunits in single striatal neurons: an RNA amplification study. Mol. Pharmacol. 49:1996;852-859.
17. Green D.R., Reed J.C. Mitochondria and apoptosis. Science. 281:1998;1309-1312.
18. Group H.S. A randomized, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington's disease. Neurology. 57:2001;397-404.
19. Gutekunst C.A., Li S.H., Yi H., Ferrante R.J., Li X.J., Hersch S.M. The cellular and subcellular localization of huntingtin-associated protein 1 (HAP1): comparison with huntingtin in rat and human. J. Neurosci. 18:1998;7674-7686.
20. Hartley D.M., Kurth M.C., Bjerkness L., Weiss J.H., Choi D.W. Glutamate receptor-induced 45Ca2+ accumulation in cortical cell culture correlates with subsequent neuronal degeneration. J. Neurosci. 13:1993;1993-2000.
21. Hodgson J.G., Agopyan N., Gutekunst C.A., Leavitt B.R., LePiane F., Singaraja R., Smith D.J., Bissada N., McCutcheon K., Nasir J., Jamot L., Li X.J., Stevens M.E., Rosemond E., Roder J.C., Phillips A.G., Rubin E.M., Hersch S.M., Hayden M.R. A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration. Neuron. 23:1999;181-192.
22. Hollmann M., Heinemann S. Cloned glutamate receptors. Annu. Rev. Neurosci. 17:1994;31-108.
23. Huntington's Disease Collaborative Research Group A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell. 72:1993;971-983.
24. Jiang D., Sullivan P.G., Sensi S.L., Steward O., Weiss J.H. Zn(2+) induces permeability transition pore opening and release of pro- apoptotic peptides from neuronal mitochondria. J. Biol. Chem. 276:2001;47524-47529.
25. Jovanovic J.N., Sihra T.S., Nairn A.C., Hemmings H.C. Jr., Greengard P., Czernik A.J. Opposing changes in phosphorylation of specific sites in synapsin I during Ca2+-dependent glutamate release in isolated nerve terminals. J. Neurosci. 21:2001;7944-7953.
26. Kirkland R.A., Franklin J.L. Evidence for redox regulation of cytochrome C release during programmed neuronal death: antioxidant effects of protein synthesis and caspase inhibition. J. Neurosci. 21:2001;1949-1963.
27. Laforet G.A., Sapp E., Chase K., McIntyre C., Boyce F.M., Campbell M., Cadigan B.A., Warzecki L., Tagle D.A., Reddy P.H., Cepeda C., Calvert C.R., Jokel E.S., Klapstein G.J., Ariano M.A., Levine M.S., DiFiglia M., Aronin N. Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington's disease. J. Neurosci. 21:2001;9112-9123.
28. Landwehrmeyer G.B., Standaert D.G., Testa C.M., Penney J.B. Jr., Young A.B. NMDA receptor subunit mRNA expression by projection neurons and interneurons in rat striatum. J. Neurosci. 15:1995;5297-5307.
29. Lee J.M., Grabb M.C., Zipfel G.J., Choi D.W. Brain tissue responses to ischemia. J. Clin. Invest. 106:2000;723-731.
30. Levine M.S., Klapstein G.J., Koppel A., Gruen E., Cepeda C., Vargas M.E., Jokel E.S., Carpenter E.M., Zanjani H., Hurst R.S., Efstratiadis A., Zeitlin S., Chesselet M.F. Enhanced sensitivity to N-methyl-D-aspartate receptor activation in transgenic and knockin mouse models of Huntington's disease. J. Neurosci. Res. 58:1999;515-532.
31. Li S.-H., Schilling G., Young W.S. 3rd, Li X.-J., Margolis R.L., Stine O.C., Wagster M.V., Abbott M.H., Fanz M.L., Ranin N.G., Folstein S.E., Hedreen J.C., Ross C.A. Huntington's disease gene (IT15) is widely expressed in human rat tissues. Neuron. 11:1993;985-993.
32. Li P., Nijhawan D., Budihardjo I., Srinivasula S.M., Ahmad M., Alnemri E.S., Wang X. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell. 91:1997;479-489.
33. Li L., Fan M., Icton C., Chen N., Leavitt B.R., Hayden M.R., Murphy T.H., Raymond L.A. Role of NR2B-type NMDA receptors in selective neurodegeneration in Huntington disease. Neurobiol. Aging. 24:2003;1113-1121.
34. Miyata K., Omori N., Uchino H., Yamaguchi T., Isshiki A., Shibasaki F. Involvement of the brain-derived neurotrophic factor/TrkB pathway in neuroprotective effect of cyclosporin A in forebrain ischemia. Neuroscience. 105:2001;571-578.
35. Nath R., Scott M., Nadimpalli R., Gupta R., Wang K.K. Activation of apoptosis-linked caspase(s) in NMDA-injured brains in neonatal rats. Neurochem. Int. 36:2000;119-126.
36. Nicholls D.G., Ward M.W. Mitochondrial membrane potential and neuronal glutamate excitotoxicity: mortality and millivolts. Trends Neurosci. 23:2000;166-174.
37. Nicholson D.W. Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death Differ. 6:1999;1028-1042.
38. Panov A.V., Gutekunst C.A., Leavitt B.R., Hayden M.R., Burke J.R., Strittmatter W.J., Greenamyre J.T. Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines. Nat. Neurosci. 5:2002;731-736.
39. Price C.J., Kim P., Raymond L.A. D1 dopamine receptor-induced cyclic AMP-dependent protein kinase phosphorylation and potentiation of striatal glutamate receptors. J. Neurochem. 73:1999;2441-2446.
40. Qin Z.H., Wang Y., Kikly K.K., Sapp E., Kegel K.B., Aronin N., DiFiglia M. Pro-caspase-8 is predominantly localized in mitochondria and released into cytoplasm upon apoptotic stimulation. J. Biol. Chem. 276:2001;8079-8086.
41. Rigby M., Le Bourdelles B., Heavens R.P., Kelly S., Smith D., Butler A., Hammans R., Hills R., Xuereb J.H., Hill R.G., Whiting P.J., Sirinathsinghji D.J. The messenger RNAs for the N-methyl-D-aspartate receptor subunits show region-specific expression of different subunit composition in the human brain. Neuroscience. 73:1996;429-447.
42. Sanberg P.R., Calderon S.F., Giordano M., Tew J.M., Norman A.B. The quinolinic acid model of Huntington's disease: locomotor abnormalities. Exp. Neurol. 105:1989;45-53.
43. Sanchez I., Xu C.J., Juo P., Kakizaka A., Blenis J., Yuan J. Caspase-8 is required for cell death induced by expanded polyglutamine repeats. (see comments) Neuron. 22:1999;623-633.
44. Sather W., Dieudonne S., MacDonald J.F., Ascher P. Activation and desensitization of N-methyl-D-aspartate receptors in nucleated outside-out patches from mouse neurones. J. Physiol. 450:1992;643-672.
45. Sattler R., Tymianski M. Molecular mechanisms of calcium-dependent excitotoxicity. J. Mol. Med. 78:2000;3-13.
46. Sawa A., Wiegand G.W., Cooper J., Margolis R.L., Sharp A.H., Lawler J.F. Jr., Greenamyre J.T., Snyder S.H., Ross C.A. Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization. Nat. Med. 5:1999;1194-1198.
47. Schuchmann S., Muller W., Heinemann U. Altered Ca2+ signaling and mitochondrial deficiencies in hippocampal neurons of trisomy 16 mice: a model of Down's syndrome. J. Neurosci. 18:1998;7216-7231.
48. Sharp A.H., Loev S.J., Schilling G., Li S.H., Li X.J., Bao J., Wagster M.V., Kotzuk J.A., Steiner J.P., Lo A.et al. Widespread expression of Huntington's disease gene (IT15) protein product. Neuron. 14:1995;1065-1074.
49. Shi W.-X., Rayport S. GABA synapses formed in vitro by local axon collaterals of nucleus accumbens neurons. J. Neurosci. 14:1994;4548-4560.
50. Stennicke H.R., Jurgensmeier J.M., Shin H., Deveraux Q., Wolf B.B., Yang X., Zhou Q., Ellerby H.M., Ellerby L.M., Bredesen D., Green D.R., Reed J.C., Froelich C.J., Salvesen G.S. Pro-caspase-3 is a major physiologic target of caspase-8. J. Biol. Chem. 273:1998;27084-27090.
51. Stout A.K., Reynolds I.J. High-affinity calcium indicators underestimate increases in intracellular calcium concentrations associated with excitotoxic glutamate stimulations. Neuroscience. 89:1999;91-100.
52. Stout A.K., Raphael H.M., Kanterewicz B.I., Klann E., Reynolds I.J. Glutamate-induced neuron death requires mitochondrial calcium uptake. Nat. Neurosci. 1:1998;366-373.
53. Vonsattel J.P., DiFiglia M. Huntington disease. J. Neuropathol. Exp. Neurol. 57:1998;369-384.
54. Wellington C.L., Leavitt B.R., Hayden M.R. Huntington disease: new insights on the role of huntingtin cleavage. J. Neural Transm., Suppl. 58:2000;1-17.
55. Wellington C.L., Singaraja R., Ellerby L., Savill J., Roy S., Leavitt B., Cattaneo E., Hackam A., Sharp A., Thornberry N., Nicholson D.W., Bredesen D.E., Hayden M.R. Inhibiting caspase cleavage of huntingtin reduces toxicity and aggregate formation in neuronal and nonneuronal cells. J. Biol. Chem. 275:2000;19831-19838.
56. Wellington C.L., Ellerby L.M., Gutekunst C.A., Rogers D., Warby S., Graham R.K., Loubser O., van Raamsdonk J., Singaraja R., Yang Y.Z., Gafni J., Bredesen D., Hersch S.M., Leavitt B.R., Roy S., Nicholson D.W., Hayden M.R. Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington's disease. J. Neurosci. 22:2002;7862-7872.
57. Yamamura T., Otani H., Nakao Y., Hattori R., Osako M., Imamura H., Das D.K. Dual involvement of coenzyme Q10 in redox signaling and inhibition of death signaling in the rat heart mitochondria. Antioxid. Redox Signal. 3:2001;103-112.
58. Young A.B., Greenamyre J.T., Hollingsworth Z., Albin R., D'Amato C., Shoulson I., Penney J.B. NMDA receptor losses in putamen from patients with Huntington's disease. Science. 241:1988;981-983.
59. Zeron M.M., Chen N., Moshaver A., Lee A.T., Wellington C.L., Hayden M.R., Raymond L.A. Mutant huntingtin enhances excitotoxic cell death. Mol. Cell. Neurosci. 17:2001;41-53.
60. Zeron M.M., Hansson O., Chen N., Wellington C.L., Leavitt B.R., Brundin P., Hayden M.R., Raymond L.A. Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease. Neuron. 33:2002;849-860.